ACHE and Alzheimer disease: Further, AD patients treated with AChE inhibitors exhibit reduced risk of hip fracture and improved bone healing, suggesting that impaired parasympathetic signaling impacts bone homeostasis in AD patients and may be targeted to improve bone health (Weller, 2004; Tamimi et al., 2012; Eimar et al., 2013).